BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chong JH, Ghosh AK. Coronary Artery Vasospasm Induced by 5-fluorouracil: Proposed Mechanisms, Existing Management Options and Future Directions.Interv Cardiol. 2019;14:89-94. [PMID: 31178935 DOI: 10.15420/icr.2019.12] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Tyebally S, Ghose A, Chen DH, Abiodun AT, Ghosh AK. Chest Pain in the Cancer Patient. Eur Cardiol 2022;17:e15. [DOI: 10.15420/ecr.2021.45] [Reference Citation Analysis]
2 Lu Y, Deng S, Dou Q, Pan W, Liu Q, Ji H, Wang X, Zhang H. Treatment-Related Coronary Disorders of Fluoropyrimidine Administration: A Systematic Review and Meta-Analysis. Front Pharmacol 2022;13:885699. [DOI: 10.3389/fphar.2022.885699] [Reference Citation Analysis]
3 Kwan JM, Oikonomou EK, Henry ML, Sinusas AJ. Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data. Front Cardiovasc Med 2022;9:829553. [PMID: 35369354 DOI: 10.3389/fcvm.2022.829553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jurczyk M, Król M, Midro A, Kurnik-Łucka M, Poniatowski A, Gil K. Cardiotoxicity of Fluoropyrimidines: Epidemiology, Mechanisms, Diagnosis, and Management. J Clin Med 2021;10:4426. [PMID: 34640443 DOI: 10.3390/jcm10194426] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Jewulski J, Khanal S, Dahal K. Coronary vasospasm: A narrative review. World J Cardiol 2021; 13(9): 456-463 [PMID: 34621490 DOI: 10.4330/wjc.v13.i9.456] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Carrillo-Estrada M, Bobrowski D, Carrasco R, Nadler MB, Kalra S, Thavendiranathan P, Abdel-Qadir H. Coronary artery disease in patients with cancer: challenges and opportunities for improvement. Curr Opin Cardiol 2021;36:597-608. [PMID: 34397466 DOI: 10.1097/HCO.0000000000000878] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Bikiewicz A, Banach M, von Haehling S, Maciejewski M, Bielecka-Dabrowa A. Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications. ESC Heart Fail 2021;8:2397-418. [PMID: 33955207 DOI: 10.1002/ehf2.13365] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
8 Mathiesen A, Hamilton T, Carter N, Brown M, McPheat W, Dobrian A. Endothelial Extracellular Vesicles: From Keepers of Health to Messengers of Disease. Int J Mol Sci 2021;22:4640. [PMID: 33924982 DOI: 10.3390/ijms22094640] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
9 Parr SK, Steele CC, Hammond ST, Turpin VRG, Ade CJ. Arterial stiffness is associated with cardiovascular and cancer mortality in cancer patients: Insight from NHANESIII. Int J Cardiol Hypertens 2021;9:100085. [PMID: 34095811 DOI: 10.1016/j.ijchy.2021.100085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Sheth MA, Widmer RJ, Dandapantula HK. Pathobiology and evolving therapies of coronary artery vasospasm. Proc (Bayl Univ Med Cent) 2021;34:352-60. [PMID: 33953459 DOI: 10.1080/08998280.2021.1898907] [Reference Citation Analysis]
11 Zafar A, Drobni ZD, Mosarla R, Alvi RM, Lei M, Lou UY, Raghu VK, Murphy SP, Jones-O'Connor M, Hartmann S, Gilman HK, Weekes CD, Clark JR, Clark J, Blaszkowsky L, Tavares E, Neilan TG. The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm. JACC CardioOncol 2021;3:101-9. [PMID: 33817666 DOI: 10.1016/j.jaccao.2020.12.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tyebally S, Abiodun A, Slater S, Ghosh AK. Treating the treatment: chemotherapy-induced multi-organ toxicity. BMJ Case Rep 2021;14:e239560. [PMID: 33722912 DOI: 10.1136/bcr-2020-239560] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 More LA, Lane S, Asnani A. 5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death. Curr Cardiol Rep 2021;23:17. [PMID: 33537861 DOI: 10.1007/s11886-021-01441-2] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
14 Hajjar LA, Costa IBSDSD, Lopes MACQ, Hoff PMG, Diz MDPE, Fonseca SMR, Bittar CS, Rehder MHHDS, Rizk SI, Almeida DR, Fernandes GDS, Beck-da-Silva L, Campos CAHM, Montera MW, Alves SMM, Fukushima JT, Santos MVCD, Negrão CE, Silva TLFD, Ferreira SMA, Malachias MVB, Moreira MDCV, Valente Neto MMR, Fonseca VCQ, Soeiro MCFA, Alves JBS, Silva CMPDC, Sbano J, Pavanello R, Pinto IMF, Simão AF, Dracoulakis MDA, Hoff AO, Assunção BMBL, Novis Y, Testa L, Alencar Filho AC, Cruz CBBV, Pereira J, Garcia DR, Nomura CH, Rochitte CE, Macedo AVS, Marcatti PTF, Mathias Junior W, Wiermann EG, Val RD, Freitas H, Coutinho A, Mathias CMC, Vieira FMAC, Sasse AD, Rocha V, Ramires JAF, Kalil Filho R. Brazilian Cardio-oncology Guideline - 2020. Arq Bras Cardiol 2020;115:1006-43. [PMID: 33295473 DOI: 10.36660/abc.20201006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
15 Moran TB, Plana JC. Management of Patients with Acute Coronary Syndrome and Cancer. Curr Cardiol Rep 2020;22. [DOI: 10.1007/s11886-020-01409-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mallouppas M, Walker JM, Guha A, Dobson R, Ghosh AK. Cardio-oncology for the general physician: 'old' and 'new' cardiovascular toxicities and how to manage them. Br J Hosp Med (Lond) 2020;81:1-11. [PMID: 32990088 DOI: 10.12968/hmed.2020.0269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Desai A, Mohammed T, Patel KN, Almnajam M, Kim AS. 5-Fluorouracil Rechallenge After Cardiotoxicity. Am J Case Rep 2020;21:e924446. [PMID: 32860674 DOI: 10.12659/AJCR.924446] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Guo P, Pi C, Zhao S, Fu S, Yang H, Zheng X, Zhang X, Zhao L, Wei Y. Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer. Expert Opinion on Drug Delivery 2020;17:1473-84. [DOI: 10.1080/17425247.2020.1796629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pushparaji B, Marmagkiolis K, Miller CK, Aziz MK, Balanescu DV, Donisan T, Palaskas N, Kim P, Lopez-mattei J, Cilingiroglu M, Hassan SA, Iliescu CA. State-of-the-art Review: Interventional Onco-Cardiology. Curr Treat Options Cardio Med 2020;22. [DOI: 10.1007/s11936-020-00809-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Pellegrini L, Sileno S, D'Agostino M, Foglio E, Florio MC, Guzzanti V, Russo MA, Limana F, Magenta A. MicroRNAs in Cancer Treatment-Induced Cardiotoxicity. Cancers (Basel) 2020;12:E704. [PMID: 32192047 DOI: 10.3390/cancers12030704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
21 Han XJ, Li JQ, Khannanova Z, Li Y. Optimal management of coronary artery disease in cancer patients. Chronic Dis Transl Med 2019;5:221-33. [PMID: 32055781 DOI: 10.1016/j.cdtm.2019.12.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Visvikis A, Kyvelou SM, Pietri P, Georgakopoulos C, Manousou K, Tousoulis D, Stefanadis C, Vlachopoulos C, Pektasides D. Cardiotoxic Profile and Arterial Stiffness of Adjuvant Chemotherapy for Colorectal Cancer. Cancer Manag Res 2020;12:1175-85. [PMID: 32104097 DOI: 10.2147/CMAR.S223032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]